2m 2m 2m 2m 2m 2m 2m
TREVI THERAPEUTI (TRVI)
NASDAQ
$15.90$0.00 (0.00%)
Price as of Sep 11, 2026 7:30 PM EDT- $2.3BMarket Cap
- 92.73%1-Year Change
- BiotechnologyIndustry
TREVI THERAPEUTI (TRVI)
$15.90$0.00 (0.00%)
TRVI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.90 | ||
Change | -$0.010 (-0.06%) | ||
Open | $16.20 | ||
High | $16.57 | ||
Low | $15.87 | ||
Previous Close | $15.91 | ||
Volume | 2,016,067 | ||
30-Day Average Volume | 1,437,279 | ||
1-Week Change | -7.88% | ||
1-Month Change | -10.67% | ||
1-Year Change | 92.73% | ||
3-Year Change | 603.54% | ||
5-Year Change | 946.05% | ||
Fundamentals | |||
Shares Outstanding | 142.5M | ||
Total Assets | $330.5M | ||
Market Cap | $2.3B | ||
Enterprise Value | $2.2B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$17.8M | ||
Free Cash Flow | -$17.6M | ||
EBIT | -$17.8M | ||
EBITDA | -$17.8M | ||
Net Working Capital | $317.0M | ||
EPS | -$0.11 | ||
Enterprise Value/EBITDA | -124 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -145 | ||
PEG | 7 | ||
Price/Free Cash Flow | -129 | ||
Price/Operating Cash Flow | -130 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue